JPI Healthcare Co.,Ltd. (KOSDAQ:0010V0)
South Korea
· Delayed Price · Currency is KRW
21,750
+1,550 (7.67%)
At close: Sep 26, 2025
JPI Healthcare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Operating Revenue | 45,323 | 45,053 | 45,412 |
| Other Revenue | -0 | -0 | -0 |
| Revenue | 45,323 | 45,053 | 45,412 |
| Revenue Growth (YoY) | - | -0.79% | - |
| Cost of Revenue | 25,006 | 25,508 | 26,623 |
| Gross Profit | 20,317 | 19,545 | 18,789 |
| Selling, General & Admin | 11,231 | 11,031 | 9,198 |
| Research & Development | 3,757 | 3,839 | 3,093 |
| Other Operating Expenses | 222.12 | 216.99 | 198.4 |
| Operating Expenses | 15,884 | 15,607 | 12,219 |
| Operating Income | 4,432 | 3,938 | 6,570 |
| Interest Expense | -446.54 | -403.47 | -326.11 |
| Interest & Investment Income | 332.36 | 355.53 | 166.96 |
| Currency Exchange Gain (Loss) | 398.17 | 683.57 | 263.56 |
| Other Non Operating Income (Expenses) | 844.91 | 1,023 | 19.6 |
| EBT Excluding Unusual Items | 5,561 | 5,597 | 6,694 |
| Gain (Loss) on Sale of Investments | 1,088 | 922.99 | 844.07 |
| Gain (Loss) on Sale of Assets | -2.8 | -2.91 | -54.9 |
| Pretax Income | 6,647 | 6,517 | 7,483 |
| Income Tax Expense | 969.25 | 964.83 | 1,144 |
| Earnings From Continuing Operations | 5,677 | 5,553 | 6,339 |
| Minority Interest in Earnings | 517.94 | 483.47 | 268.96 |
| Net Income | 6,195 | 6,036 | 6,608 |
| Preferred Dividends & Other Adjustments | 827.28 | 1,101 | 720.3 |
| Net Income to Common | 5,368 | 4,935 | 5,888 |
| Net Income Growth | - | -8.66% | - |
| Shares Outstanding (Basic) | 2 | 2 | 2 |
| Shares Outstanding (Diluted) | 4 | 4 | 4 |
| EPS (Basic) | 2263.72 | 2350.00 | 2803.68 |
| EPS (Diluted) | 1490.23 | 1451.66 | 1589.23 |
| EPS Growth | - | -8.66% | - |
| Free Cash Flow | -7,184 | -6,982 | 3,710 |
| Free Cash Flow Per Share | -1727.84 | -1679.24 | 892.14 |
| Dividend Per Share | 160.000 | 160.000 | 350.000 |
| Dividend Growth | - | -54.29% | - |
| Gross Margin | 44.83% | 43.38% | 41.38% |
| Operating Margin | 9.78% | 8.74% | 14.47% |
| Profit Margin | 11.84% | 10.95% | 12.96% |
| Free Cash Flow Margin | -15.85% | -15.50% | 8.17% |
| EBITDA | 6,002 | 5,532 | 8,132 |
| EBITDA Margin | 13.24% | 12.28% | 17.91% |
| D&A For EBITDA | 1,570 | 1,594 | 1,562 |
| EBIT | 4,432 | 3,938 | 6,570 |
| EBIT Margin | 9.78% | 8.74% | 14.47% |
| Effective Tax Rate | 14.58% | 14.80% | 15.29% |
| Advertising Expenses | - | 1,083 | 921.85 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.